Compare CGC & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGC | NAGE |
|---|---|---|
| Founded | N/A | 1999 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.6M | 507.6M |
| IPO Year | 2023 | N/A |
| Metric | CGC | NAGE |
|---|---|---|
| Price | $1.19 | $4.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | N/A | ★ $16.33 |
| AVG Volume (30 Days) | ★ 10.9M | 732.8K |
| Earning Date | 05-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.75 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,759,000.00 | N/A |
| Revenue This Year | $6.79 | $30.37 |
| Revenue Next Year | $7.34 | $20.36 |
| P/E Ratio | ★ N/A | $21.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $4.93 |
| 52 Week High | $2.38 | $14.66 |
| Indicator | CGC | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 53.97 | 27.23 |
| Support Level | $1.02 | $4.93 |
| Resistance Level | $1.15 | $5.32 |
| Average True Range (ATR) | 0.06 | 0.26 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 80.95 | 6.72 |
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.